Ovid Therapeutics Inc. (OVID) Reports In-Line Q1 EPS

Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12).

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Gil Issachar steps down as CTO at Firefly Neuroscience
• Groq raises $650m to expand AI inference cloud operations